Outcomes of prolonged and low-dose ciclosporin in an Asian population
Background Ciclosporin is used in dermatology for a variety of conditions. Existing guidelines commonly recommend a starting dose of 3–5 mg/kg/day. Objectives We sought to assess response in our cohort of patients in whom lower doses of ciclosporin were used, and compare the efficacy and side effect...
Main Authors: | Ellie Choi, Alex Cook, Crystal Phuan, Aaron Martin, Sam Yang, Derrick Aw, Nisha Suyien Chandran |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-05-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09546634.2019.1662881 |
Similar Items
-
Dermatologist attitudes toward ciclosporin use in atopic dermatitis
by: Kevin Phan, et al.
Published: (2021-11-01) -
Comparative study to evaluate the voluntary acceptance of two liquid oral formulations of ciclosporin in dogs
by: Srinivas J. Kammanadiminti, et al.
Published: (2018-12-01) -
Low-dose ciclosporin therapy of erythrodermic psoriasis
by: Ryszard Galus, et al.
Published: (2014-07-01) -
UK Dermatology Clinical Trials Network’s STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial
by: Craig Fiona F, et al.
Published: (2012-04-01) -
Cyclosporine in dermatology results of a pilot study
by: Rahul Ray, et al.
Published: (2013-01-01)